Drug interactions
ciprofloxacin + sulfamethoxazole/trimethoprim
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Overview
Additive risk of QTc prolongation with potential for torsades de pointes, especially in patients with additional risk factors (baseline prolonged QT, electrolyte abnormalities, bradycardia, structural heart disease, high doses, renal impairment, or concurrent QT‑prolonging drugs).
Mechanism of action
Pharmacodynamic: both agents can delay cardiac repolarization (IKr/hERG blockade), leading to additive QTc prolongation; ciprofloxacin has established QT risk, while trimethoprim-sulfamethoxazole has rare case reports.
Clinical management
Avoid the combination in patients at increased torsades risk when alternatives exist. If used, correct potassium and magnesium, avoid other QT‑prolonging agents, use the lowest effective doses and shortest duration, and obtain baseline and follow-up ECG in high‑risk patients. Educate patients to report palpitations, dizziness, or syncope.
Drug reference
References
- Ciprofloxacin US Prescribing Information – Warnings and Precautions: Prolongation of the QT Interval and Torsade de Pointes — FDA Label
- Drug-induced QT prolongation (acquired long QT): Epidemiology, risk factors, and prevention — UpToDate
- Sulfamethoxazole and Trimethoprim: Drug Interactions and Adverse Reactions (QT prolongation caution) — Lexicomp
Frequently asked questions
Can I take ciprofloxacin with sulfamethoxazole/trimethoprim?
The interaction is rated: Moderate. Additive risk of QTc prolongation with potential for torsades de pointes, especially in patients with additional risk factors (baseline prolonged QT, electrolyte abnormalities, bradycardia, structural heart disease, high doses, renal impairment, or concurrent QT‑prolonging drugs).
How serious is the interaction between ciprofloxacin and sulfamethoxazole/trimethoprim?
The interaction is rated: Moderate. Evidence level: Moderate.
How is the interaction between ciprofloxacin and sulfamethoxazole/trimethoprim managed?
Avoid the combination in patients at increased torsades risk when alternatives exist. If used, correct potassium and magnesium, avoid other QT‑prolonging agents, use the lowest effective doses and shortest duration, and obtain baseline and follow-up ECG in high‑risk patients. Educate patients to report palpitations, dizziness, or syncope.
Why do ciprofloxacin and sulfamethoxazole/trimethoprim interact?
Pharmacodynamic: both agents can delay cardiac repolarization (IKr/hERG blockade), leading to additive QTc prolongation; ciprofloxacin has established QT risk, while trimethoprim-sulfamethoxazole has rare case reports.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.